Garth Powis
Affiliations: | University of Arizona, Tucson, AZ |
Area:
Cell Biology, Biochemistry, Molecular BiologyGoogle:
"Garth Powis"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Bryan E. Husbeck | grad student | 2002 | University of Arizona |
| Larisa Nonn | grad student | 2003 | University of Arizona |
| Warner B. Bair | grad student | 2006 | University of Arizona |
| Amy E. Coon | grad student | 2006 | University of Arizona |
| Kara E. Rogers | grad student | 2006 | University of Arizona |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jeung HC, Delaney R, Aleshin A, et al. (2021) PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancer. Experimental Cell Research. 112930 |
| Maruggi M, Layng FIAL, Lemos R, et al. (2019) Absence of HIF1A leads to glycogen accumulation and an inflammatory response that enables pancreatic tumor growth. Cancer Research |
| Indarte M, Puentes R, Maruggi M, et al. (2019) An inhibitor of the pleckstrin homology domain of CNK1 selectively blocks the growth of mutant KRAS cells and tumors. Cancer Research |
| Campos AD, James B, Jong PD, et al. (2018) Abstract 2428: Redox regulation of β-catenin in colorectal cancer Cancer Research. 78: 2428-2428 |
| Grandjean G, De Jong PR, James BP, et al. (2016) Definition of a novel feed-forward mechanism for glycolysis-HIF1α signaling in hypoxic tumors highlights adolase A as a therapeutic target. Cancer Research |
| Lee MS, Helms TL, Feng N, et al. (2016) Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models. Oncotarget |
| Nam S, Chang HR, Jung HR, et al. (2015) A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer. Cancer Letters. 356: 880-90 |
| Koh MY, Nguyen V, Lemos R, et al. (2015) Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma. Cancer Research. 75: 316-29 |
| Kirkpatrick DL, Indarte M, Scott M, et al. (2015) Abstract 2583: Refinement of inhibitors of the KRAS-signaling naocluster protein, CNKSR1, that block oncogenic KRAS signaling and growth Cancer Research. 75: 2583-2583 |
| Nam S, Chang HR, Kim KT, et al. (2014) PATHOME: an algorithm for accurately detecting differentially expressed subpathways. Oncogene. 33: 4941-51 |